Product Information
INVEGA HAFYERA 1,560 MG/5 ML is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $4233.4015 per ML under NDC 50458061201. Its NADAC has been published 80 times since Dec 18, 2024.
Strength
1560 mg/5mL
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458061201
Classification
Brand
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Last Updated
1/2/2026
Active Ingredients
PALIPERIDONE PALMITATEApproval Type
New Drug (NDA)
FDA Application
NDA207946On Market Since
8/30/2021
Pharmacological Classes
Price Statistics
The NADAC for INVEGA HAFYERA 1,560 MG/5 ML has been published 80 times since Dec 18, 2024, and over the history we have for it it has risen 5.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4233.4015 per ML |
|---|---|
| All-time high | $4233.4015 (Jun 24, 2026) |
| All-time low | $4029.4163 (Dec 18, 2024) |
| 52-week high | $4233.4015 |
| 52-week low | $4134.1812 |
| Median price | $4134.1812 |
| Average price | $4158.7090 |
| Largest weekly change | +2.6% (Jan 15, 2025) |
| Weeks tracked | 80 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the paliperidone palmitate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of INVEGA HAFYERA 1,560 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for INVEGA HAFYERA 1,560 MG/5 ML, manufactured by Janssen Pharmaceuticals Inc., is $4233.4015 per ML (NDC 50458061201), effective Jun 24, 2026.
How has the price of INVEGA HAFYERA 1,560 MG/5 ML changed over time?
Over the history we have for it, the NADAC for INVEGA HAFYERA 1,560 MG/5 ML has risen 5.1%. It has been tracked across 80 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for INVEGA HAFYERA 1,560 MG/5 ML?
Since Dec 18, 2024, the NADAC for INVEGA HAFYERA 1,560 MG/5 ML has ranged from a low of $4029.4163 (Dec 18, 2024) to a high of $4233.4015 (Jun 24, 2026), with a median of $4134.1812 per ML.
Are there cheaper alternatives to INVEGA HAFYERA 1,560 MG/5 ML?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of INVEGA HAFYERA 1,560 MG/5 ML, so no direct lower-cost alternative is listed.
Who manufactures INVEGA HAFYERA 1,560 MG/5 ML?
INVEGA HAFYERA 1,560 MG/5 ML (NDC 50458061201) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification